|
- Automation of Reports and Consolidated Orders System (ARCOS)
What is ARCOS and What Does it Do? The Controlled Substances Act of 1970 (§ 827) created the requirement for Manufacturers and Distributors to report their controlled substances transactions to the Attorney General
- Diversion Control Division | Reporting
Background: What is ARCOS and What Does it Do?
- ARCOS - Data Portal
Automation of Reports and Consolidated Orders System (ARCOS) is a nationwide system through which manufacturers and distributors report transactions of controlled substances to the Drug Enforcement Agency (DEA) of the United States Through this portal, users can access a version of the ARCOS data
- DEA announces enhanced tool for registered drug manufacturers and . . .
In February 2018, DEA launched a new tool in its ARCOS Online Reporting System to assist drug manufacturers and distributors with their regulatory obligations under the Controlled Substances Act
- ARCOS On-line Reporting - United States Department of Justice
SORS Registration (for Non-ARCOS Reporters) Re-send SORS Registration Email Recover Account Reset Password
- Reports Module - OSCAR Portal
The Reports Module in ARCOS contains access to most of the reporting capabilities in the system Reports in ARCOS are read-only and cannot be edited However, all reports in ARCOS can either be printed to hard copy or exported as a CSV file
- ARCOS Handbook
An ARCOS report consists of a single control record and all transaction records associated with the same reporting registrant number Each ARCOS transaction belongs to one of the following five (5) categories: current transactions, corrections, deletions, adjustments, or late transactions
- eCFR :: 21 CFR 1304. 33 -- Reports to Automation of Reports and . . .
In addition to reporting acquisition distribution transactions, each person who is registered to manufacture controlled substances in bulk or dosage form shall report manufacturing transactions on controlled substances in Schedules I and II, each narcotic controlled substance listed in Schedules III, IV, and V, gamma-hydroxybutyric acid drug
|
|
|